Non-invasive risk assessment in patients with chronic kidney disease

Journal of Nuclear Cardiology

Volumn 18, Issue 3, 2011, Pages 472-485

  Hakeem, Abdul ^a   Bhatti, Sabha ^a   Trevino, Alejandro R ^b   Samad, Zainab ^c   Chang, Su Min ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; CALCIUM;

ANGIOCARDIOGRAPHY; ARTERIAL WALL THICKNESS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; ELECTRON BEAM TOMOGRAPHY; FATTY ACID METABOLISM; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; INTERMETHOD COMPARISON; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; MORBIDITY; MYOCARDIAL PERFUSION IMAGING; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PHARMACOLOGIC STRESS TESTING; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RENAL REPLACEMENT THERAPY; REVIEW; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY;

CARDIOVASCULAR DISEASES; COMORBIDITY; HUMANS; KIDNEY FAILURE, CHRONIC; MYOCARDIAL PERFUSION IMAGING; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 79960397017     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-011-9359-y     Document Type: Review

References (84)

1. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Chronic kidney disease as a global public health problem: Approaches and initiatives-a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007;72:247-59. (Pubitemid 47172384)
2. Centers for Disease Control and Prevention. United States. Chronic Kidney Disease Surveillance System. Atlanta. U.S. Department of Health and Human Services, 2010. http://www.cdc. gov/diabetes/projects/kidney.htm.
3. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-47. (Pubitemid 350074801)
4. Plantinga LC, Boulware LE, Coresh J, Stevens LA, Miller ER III, et al. Patient awareness of chronic kidney disease: Trends and predictors. Arch Intern Med 2008;168:2268-75.
5. Meisinger C, Doring A, Lowel H, KORA Study Group. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population. Eur Heart J 2006;27: 1245-50.
6. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305.
7. Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, Coresh J, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes and mortality in community. J Am Coll Cardiol 2003;41:47-55. (Pubitemid 36044403)
8. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol 2004;15:1307-15. (Pubitemid 38526012)
9. National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report JAMA 2003; 289: 2560-71.
10. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-266.
11. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004;351:1285-95. (Pubitemid 39258422)
12. Gibson CM, Dumaine RL, Gelfand EV, Murphy SA, Morrow DA, Wiviott SD, et al. Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome: Observations in 13307 patients in five TIMI trials. Eur Heart J 2004;25:1998-2005. (Pubitemid 39486018)
13. Jose P, Skali H, Anavekar N, Tomson C, Krumholz HM, Rouleau JL, et al. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol 2006;17:2886-91. (Pubitemid 44484679)
14. Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, et al. Renal impairment and outcomes in heart failure: Systematic review and meta-analysis. J Am Coll Cardiol 2006;47:1987-96.
15. Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: The Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation 2006;113:2713-23. (Pubitemid 43947989)
16. Devbhandari MP, Duncan AJ, Grayson AD, Fabri BM, Keenan DJ, Bridgewater B, et al. Effect of risk-adjusted, non-dialysis-dependent renal dysfunction on mortality and morbidity following coronary artery bypass surgery: A multi-centre study. Eur J Car-diothorac Surg 2006;29:964-70. (Pubitemid 43728594)
17. Cooper WA, O'Brien SM, Thourani VH, Guyton RA, Bridges CR, Szczech LA, et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: Results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation 2006;113:1063-70.
18. Aoki J, Ong AT, Hoye A, van Herwerden LA, Sousa JE, Jatene A, et al. Five year clinical effect of coronary stenting and coronary bypass grafting in renal insufficient patients with multivessel coronary artery disease: Insights from ARTS trial. Eur Heart J 2005;26:1488-93. (Pubitemid 41373488)
19. Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002;39:1113-9. (Pubitemid 34267412)
20. Sadeghi HM, Stone GW, Grines CL, Mehran R, Dixon SR, et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 2003;108: 2769-75. (Pubitemid 37498979)
21. Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet 2010;375:2073-81.
22. Sarnak MJ. Cardiovascular complications in chronic kidney disease. Am J Kidney Dis 2003;41:11-7.
23. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity, and mortality in end stage renal disease. Am J Kidney Dis 1996;28: 53-61. (Pubitemid 26231466)
24. Metivier F, Marchais SJ, Guerin AP, Pannier B, London GM. Pathophysiology of anaemia: Focus on the heart and blood vessels. Nephrol Dial Transplant 2000;15:14-8.
25. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;108:2154-69.
26. Zoccali C. Left ventricular systolic dysfunction: A sudden killer in end-stage renal disease patients. Hypertension 2010;56:187-8.
27. Levin A, Thompson CR, Ethier J, et al. Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. Am J Kidney Dis 1999;34:125-34. (Pubitemid 29318806)
28. Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS, et al. The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol 2007;50:217-24. (Pubitemid 47031564)
29. Rakhit DJ, Armstrong KA, Beller E, Isbel NM, Marwick TH. Risk stratification of patients with chronic kidney disease: Results of screening strategies incorporating clinical risk scoring and dobu-tamine stress echocardiography. Am Heart J 2006;152:363-70. (Pubitemid 44093400)
30. Hage FG, Venkataraman R, Zoghbi GJ, Perry G, DeMattos A, Iskandrian AE. The scope of coronary heart disease in patients with chronic kidney disease. J Am Coll Cardiol 2009;53:2129-40.
31. Ragosta M, Samady H, Isaacs RB, Gimple LW, Sarembock IJ, Powers ER. Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries. Am Heart J 2004;147:1017-23. (Pubitemid 38880957)
32. Yuda S, Khoury V, Marwick TH. Influence of wall stress and left ventricular geometry on the accuracy of dobutamine stress echo-cardiography. J Am Coll Cardiol 2002;40:1311-9.
33. Topol EJ, Nissen SE. Our preoccupation with coronary luminol-ogy. The dissociation between clinical and angiographic findings in ischemic heart disease. Circulation 1995;92:2333-42.
34. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Stress myocardial perfusion single-photon emission computed tomography is clinically effective and cost effective in risk stratification of patients with a high likelihood of coronary artery disease (CAD) but no known CAD. J Am Coll Cardiol 2004;43: 200-8. (Pubitemid 38201145)
35. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: Incremental prognostic value and use in risk stratification. Circulation 1996;93: 905-14. (Pubitemid 26074827)
36. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: Differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-43. (Pubitemid 28090682)
37. Valeti US, Miller TD, Hodge DO, Gibbons RJ. Exercise single-photon emission computed tomography provides effective risk stratification of elderly men and elderly women. Circulation 2005;111:1771-6. (Pubitemid 40525141)
38. Shaw LJ, Hendel RC, Cerquiera M, Mieres JH, Alazraki N, Kra-wczynska E, et al. Ethnic differences in the prognostic value of stress technetium-99m tetrofosmin gated single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol 2005;45:1494-504. (Pubitemid 40615625)
39. Amanullah AM, Berman DS, Erel J, Kiat H, Cohen I, Germano G, et al. Incremental prognostic value of adenosine myocardial per-fusion single-photon emission computed tomography in women with suspected coronary artery disease. Am J Cardiol 1998;82: 725-30.
40. Berman DS, Kang X, Hayes SW, Friedman JD, Cohen I, Abidov A, et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am CollCardiol 2003;41:1125-33. (Pubitemid 36384899)
41. Lippert J, Ritz E, Schwarzbeck A, et al. The rising tide of endstage renal failure from diabetic nephropathy type II-An epidemio-logical analysis. Nephrol Dial Transplant 1995;10:462-7.
42. Cook JR, Dillie KS, Hakeem A, Bhatti S, Chang SM. Effectiveness of anemia and chronic kidney disease as predictors for presence and severity of coronary artery disease in patients undergoing stress myocardial perfusion study. Am J Cardiol 2008;102:266-71.
43. Chonchol M, Whittle J, Desbien A, Orner MB, Petersen LA, Kressin NR. Chronic kidney disease is associated with angio-graphic coronary artery disease. Am J Nephrol 2008;28:354-60.
44. Karagiannis SE, Feringa HH, Elhendy A, van Domburg R, Chonchol M, Vidakovic R, et al. Prognostic significance of renal function in patients undergoing dobutamine stress echocardiogra-phy. Nephrol Dial Transplant 2008;23:601-7. (Pubitemid 351767632)
45. Hakeem A, Bhatti S, Dillie KS, Cook JR, Samad Z, Roth-Cline MD, et al. Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death. Circulation 2008;118:2540-9.
46. Coceani M, Gimelli A, Carpeggiani C, L'abbate A, Marzullo P. Clinical utility of estimated glomerular filtration rate in patients undergoing gated SPECT. J Nucl Cardiol 2009;16:384-90.
47. Al-Mallah MH, Hachamovitch R, Dorbala S, Di Carli MF. Incremental prognostic value of myocardial perfusion imaging in patients referred to stress single-photon emission computed tomography with renal dysfunction. Circ Cardiovasc Imaging 2009;2:429-36.
48. Hatta T, Nishimura S, Nishimura T. Prognostic risk stratification of myocardial ischaemia evaluated by gated myocardial perfusion SPECT in patients with chronic kidney disease. Eur J Nucl Med Mol Imaging 2009;36:1835-41.
49. Young LH, Wackers FJ, Chyun DA, Davey JA, Barrett EJ, Taillefer R, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: The DIAD study: A randomized controlled trial. JAMA 2009;301: 1547-55.
50. Hakeem A, Bhatti S, Karmali KN, Dillie KS, Cook JR, Xu J, et al. Renal function and risk stratification of diabetic and nondiabetic patients undergoing evaluation for coronary artery disease. JACC Cardiovasc Imaging 2010;3:734-45.
51. Rabbat CG, Treleaven DJ, Russell JD, Ludwin D, Cook DJ. Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: A meta-analysis. J Am Soc Nephrol 2003;14: 431-9. (Pubitemid 36150867)
52. Patel AD, Abo-Auda WS, Davis JM, Zoghbi GJ, Deierhoi MH, Heo J, et al. Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation. Am J Cardiol 2003;92:146-51. (Pubitemid 36835962)
53. Dussol B, Bonnet JL, Sampol J, Savin B, De La Forte C, Mundler O, et al. Prognostic value of inducible myocardial ischemia in predicting cardiovascular events after renal transplantation. Kidney Int 2004;66:1633-9. (Pubitemid 39298399)
54. Venkataraman R, Hage FG, Dorfman T, Heo J, Aquel RA, de Mattos AM, et al. Role of myocardial perfusion imaging in patients with end-stage renal disease undergoing coronary angi-ography. Am J Cardiol 2008;102:1451-6.
55. Bergeron S, Hillis GS, Haugen EN, Oh JK, Bailey KR, Pellikka PA. Prognostic value of dobutamine stress echocardiography in patients with chronic kidney disease. Am Heart J 2007;153: 385-91. (Pubitemid 46328755)
56. Tita C, Karthikeyan V, Stroe A, Jacobsen G, Ananthasubramaniam K. Stress echocardiography for risk stratification in patients with end-stage renal disease undergoing renal transplantation. J Am Soc Echocardiogr 2008;21:321-6.
57. Sobkowicz B, Tomaszuk-Kazberuk A, Malyszko J, Kalinowski M, Hryszko T, Kralisz P, et al. Value of the real-time myocardial contrast echocardiography for risk stratification and for the detection of significant coronary stenosis in patients with end-stage renal disease. Nephrol Dial Transplant 2007;22:668-9. (Pubitemid 46189930)
58. Bart BA, Cen YY, Hendel RC, Lee R, Marwick TH, Missov ED, et al. Comparison of dobutamine stress echocardiography, dobu-tamine SPECT, and adenosine SPECT myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol 2009;16:507-15.
59. De Lima JJ, Sabbaga E, Vieira ML, de Paula FJ, Ianhez LE, Krieger EM, et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension 2003;42:263-8. (Pubitemid 37093471)
60. Nishimura M, Tsukamoto K, Hasebe N, Tamaki N, Kikuchi K, Ono T. Prediction of cardiac death in hemodialysis patients by myocardial fatty acid imaging. J Am Coll Cardiol 2008;51:139-45.
61. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 meta-iodobenzylguani-dine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 2010;55:2212-21.
62. Gerson MC, Abdallah M, Muth JN, Costea AI. Will imaging assist in the selection of patients with heart failure for an ICD? JACC Cardiovasc Imaging 2010;3:101-10.
63. Furuhashi T, Moroi M. Importance of renal function on prognostic value of cardiac iodine-123 metaiodobenzylguanidine scintigra-phy. Ann Nucl Med 2007;21:57-63. (Pubitemid 46280150)
64. Mark PB, Johnston N, Groenning BA, et al. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int 2006;69:1839-45. (Pubitemid 43739213)
65. Canavese C, Mereu MC, Aime S, et al. Gadolinium-associated nephrogenic systemic fibrosis: The need for nephrologists' awareness. J Nephrol 2008;21:324-36.
66. Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 2000;15:218-23. (Pubitemid 30064276)
67. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC. Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients. Am J Kidney Dis 1996; 27:394-401. (Pubitemid 26075849)
68. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000;342:1478-83. (Pubitemid 30318271)
69. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002;39:695-701. (Pubitemid 34158168)
70. Ohtake T, Ishioka K, Honda K, Oka M, Maesato K, Mano T, et al. Impact of coronary artery calcification in hemodialysis patients: Risk factors and associations with prognosis. Hemodial Int 2010;14:218-25.
71. Dellegrottaglie S, Saran R, Gillespie B, Zhang X, Chung S, Fin-kelstein F, et al. Prevalence and predictors of cardiovascular calcium in chronic kidney disease (from the Prospective Longitudinal RRI-CKD Study). Am J Cardiol 2006;98:571-6. (Pubitemid 44233449)
72. Garland JS, Holden RM, Groome PA, Lam M, Nolan RL, Morton AR, et al. Prevalence and associations of coronary artery calcification in patients with stages 3 to 5 CKD without cardiovascular disease. Am J Kidney Dis 2008;52:849-58.
73. Kramer H, Toto R, Peshock R, Cooper R, Victor R. Association between chronic kidney disease and coronary artery calcification: The Dallas heart study. J Am Soc Nephrol 2005;16:507-13. (Pubitemid 41725148)
74. Fox CS, Larson MG, Keyes MJ, Levy D, Clouse ME, Culleton B, et al. Kidney function is inversely associated with coronary artery calcification in men and women free of cardiovascular disease: The Framingham Heart Study. Kidney Int 2004;66:2017-21.
75. Chiu YW, Adler SG, Budoff MJ, Takasu J, Ashai J, Mehrotra R. Coronary artery calcification and mortality in diabetic patients with proteinuria. Kidney Int 2010;77:1107-14.
76. Papagianni A, Dovas S, Bantis C, Belechri AM, Kalovoulos M, Dimitriadis C, et al. Carotid atherosclerosis and endothelial cell adhesion molecules as predictors of long-term outcome in chronic hemodialysis patients. Am J Nephrol 2008;28:265-74.
77. Szeto CC, Chow KM, Woo KS, Chook P, Ching-Ha Kwan B, Leung CB, et al. Carotid intima media thickness predicts cardiovascular diseases in Chinese predialysis patients with chronic kidney disease. J Am Soc Nephrol 2007;18:1966-72. (Pubitemid 46870335)
78. Charytan D, Kuntz RE. The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int 2006;70:2021-30. (Pubitemid 44863392)
79. Hachamovitch R, Hayes S, Friedman JD, Cohen I, Shaw LJ, Germano G, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: What is the warranty period of a normal scan? J Am Coll Cardiol 2003;41:1329-40. (Pubitemid 36438995)
80. Anand DV, Lim E, Hopkins D, et al. Risk stratification in uncomplicated type 2 diabetes: Prospective evaluationof the combined use of coronary artery calcium imaging and selective myocardial per-fusionscintigraphy. Eur Heart J 2006;27:713-21.
81. Marwick TH, Lauer MS, Lobo A, Nally J, Braun W. Use of dobutamine echocardiography for cardiac risk stratification of patients with chronic renal failure. J Intern Med 1998;244:155-61. (Pubitemid 28364801)
82. Bhatti S, Hakeem A, Dillie KS, Cook JR, Chang SM. Prevalence, prognosis, and therapeutic implications of unrecognized left ventricular systolic dysfunction in patients with anemia and chronic kidney disease. Congest Heart Fail 2010;16:271-7.
83. Chang SM, Nabi FN, Xu J, Peterson LE, Achari A, Pratt CM, et al. The Coronary Artery Calcium Score and Stress Myocardial Per-fusion Imaging Provide Independent and Complementary Prediction of Cardiac Risk. J Am Coll Cardiol 2009;54:1872-82.
84. Schenker MP, Dorbala S, Hong EC, et al. Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: A combined positron emission tomography/computed tomography study. Circulation 2008;117:1693-700. (Pubitemid 351482594)